[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Retinoic Acid Receptor Beta Market Growth 2022-2028

January 2022 | 93 pages | ID: G70BABCCA498EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Retinoic Acid Receptor Beta will have significant change from previous year. According to our (LP Information) latest study, the global Retinoic Acid Receptor Beta market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Retinoic Acid Receptor Beta market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Retinoic Acid Receptor Beta market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Retinoic Acid Receptor Beta market, reaching US$ million by the year 2028. As for the Europe Retinoic Acid Receptor Beta landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Retinoic Acid Receptor Beta players cover 3SBio Inc, Lee's Pharmaceutical Holdings Ltd, Phosphagenics Ltd, and Promius Pharma LLC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Retinoic Acid Receptor Beta market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Alitretinoin
  • SBD-073
  • Tamibarotene
  • Tazarotene
  • Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Metabolic Disorders
  • Hemotological Disorders
  • Oncology
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • 3SBio Inc
  • Lee's Pharmaceutical Holdings Ltd
  • Phosphagenics Ltd
  • Promius Pharma LLC
  • Sol-Gel Technologies Ltd
  • Valeant Pharmaceuticals International Inc
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Retinoic Acid Receptor Beta Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Retinoic Acid Receptor Beta by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Retinoic Acid Receptor Beta by Country/Region, 2017, 2022 & 2028
2.2 Retinoic Acid Receptor Beta Segment by Type
  2.2.1 Alitretinoin
  2.2.2 SBD-073
  2.2.3 Tamibarotene
  2.2.4 Tazarotene
  2.2.5 Others
2.3 Retinoic Acid Receptor Beta Sales by Type
  2.3.1 Global Retinoic Acid Receptor Beta Sales Market Share by Type (2017-2022)
  2.3.2 Global Retinoic Acid Receptor Beta Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Retinoic Acid Receptor Beta Sale Price by Type (2017-2022)
2.4 Retinoic Acid Receptor Beta Segment by Application
  2.4.1 Metabolic Disorders
  2.4.2 Hemotological Disorders
  2.4.3 Oncology
  2.4.4 Others
2.5 Retinoic Acid Receptor Beta Sales by Application
  2.5.1 Global Retinoic Acid Receptor Beta Sale Market Share by Application (2017-2022)
  2.5.2 Global Retinoic Acid Receptor Beta Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Retinoic Acid Receptor Beta Sale Price by Application (2017-2022)

3 GLOBAL RETINOIC ACID RECEPTOR BETA BY COMPANY

3.1 Global Retinoic Acid Receptor Beta Breakdown Data by Company
  3.1.1 Global Retinoic Acid Receptor Beta Annual Sales by Company (2020-2022)
  3.1.2 Global Retinoic Acid Receptor Beta Sales Market Share by Company (2020-2022)
3.2 Global Retinoic Acid Receptor Beta Annual Revenue by Company (2020-2022)
  3.2.1 Global Retinoic Acid Receptor Beta Revenue by Company (2020-2022)
  3.2.2 Global Retinoic Acid Receptor Beta Revenue Market Share by Company (2020-2022)
3.3 Global Retinoic Acid Receptor Beta Sale Price by Company
3.4 Key Manufacturers Retinoic Acid Receptor Beta Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Retinoic Acid Receptor Beta Product Location Distribution
  3.4.2 Players Retinoic Acid Receptor Beta Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR RETINOIC ACID RECEPTOR BETA BY GEOGRAPHIC REGION

4.1 World Historic Retinoic Acid Receptor Beta Market Size by Geographic Region (2017-2022)
  4.1.1 Global Retinoic Acid Receptor Beta Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Retinoic Acid Receptor Beta Annual Revenue by Geographic Region
4.2 World Historic Retinoic Acid Receptor Beta Market Size by Country/Region (2017-2022)
  4.2.1 Global Retinoic Acid Receptor Beta Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Retinoic Acid Receptor Beta Annual Revenue by Country/Region
4.3 Americas Retinoic Acid Receptor Beta Sales Growth
4.4 APAC Retinoic Acid Receptor Beta Sales Growth
4.5 Europe Retinoic Acid Receptor Beta Sales Growth
4.6 Middle East & Africa Retinoic Acid Receptor Beta Sales Growth

5 AMERICAS

5.1 Americas Retinoic Acid Receptor Beta Sales by Country
  5.1.1 Americas Retinoic Acid Receptor Beta Sales by Country (2017-2022)
  5.1.2 Americas Retinoic Acid Receptor Beta Revenue by Country (2017-2022)
5.2 Americas Retinoic Acid Receptor Beta Sales by Type
5.3 Americas Retinoic Acid Receptor Beta Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Retinoic Acid Receptor Beta Sales by Region
  6.1.1 APAC Retinoic Acid Receptor Beta Sales by Region (2017-2022)
  6.1.2 APAC Retinoic Acid Receptor Beta Revenue by Region (2017-2022)
6.2 APAC Retinoic Acid Receptor Beta Sales by Type
6.3 APAC Retinoic Acid Receptor Beta Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Retinoic Acid Receptor Beta by Country
  7.1.1 Europe Retinoic Acid Receptor Beta Sales by Country (2017-2022)
  7.1.2 Europe Retinoic Acid Receptor Beta Revenue by Country (2017-2022)
7.2 Europe Retinoic Acid Receptor Beta Sales by Type
7.3 Europe Retinoic Acid Receptor Beta Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Retinoic Acid Receptor Beta by Country
  8.1.1 Middle East & Africa Retinoic Acid Receptor Beta Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Retinoic Acid Receptor Beta Revenue by Country (2017-2022)
8.2 Middle East & Africa Retinoic Acid Receptor Beta Sales by Type
8.3 Middle East & Africa Retinoic Acid Receptor Beta Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Retinoic Acid Receptor Beta
10.3 Manufacturing Process Analysis of Retinoic Acid Receptor Beta
10.4 Industry Chain Structure of Retinoic Acid Receptor Beta

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Retinoic Acid Receptor Beta Distributors
11.3 Retinoic Acid Receptor Beta Customer

12 WORLD FORECAST REVIEW FOR RETINOIC ACID RECEPTOR BETA BY GEOGRAPHIC REGION

12.1 Global Retinoic Acid Receptor Beta Market Size Forecast by Region
  12.1.1 Global Retinoic Acid Receptor Beta Forecast by Region (2023-2028)
  12.1.2 Global Retinoic Acid Receptor Beta Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Retinoic Acid Receptor Beta Forecast by Type
12.7 Global Retinoic Acid Receptor Beta Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 3SBio Inc
  13.1.1 3SBio Inc Company Information
  13.1.2 3SBio Inc Retinoic Acid Receptor Beta Product Offered
  13.1.3 3SBio Inc Retinoic Acid Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 3SBio Inc Main Business Overview
  13.1.5 3SBio Inc Latest Developments
13.2 Lee's Pharmaceutical Holdings Ltd
  13.2.1 Lee's Pharmaceutical Holdings Ltd Company Information
  13.2.2 Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Beta Product Offered
  13.2.3 Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Lee's Pharmaceutical Holdings Ltd Main Business Overview
  13.2.5 Lee's Pharmaceutical Holdings Ltd Latest Developments
13.3 Phosphagenics Ltd
  13.3.1 Phosphagenics Ltd Company Information
  13.3.2 Phosphagenics Ltd Retinoic Acid Receptor Beta Product Offered
  13.3.3 Phosphagenics Ltd Retinoic Acid Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Phosphagenics Ltd Main Business Overview
  13.3.5 Phosphagenics Ltd Latest Developments
13.4 Promius Pharma LLC
  13.4.1 Promius Pharma LLC Company Information
  13.4.2 Promius Pharma LLC Retinoic Acid Receptor Beta Product Offered
  13.4.3 Promius Pharma LLC Retinoic Acid Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Promius Pharma LLC Main Business Overview
  13.4.5 Promius Pharma LLC Latest Developments
13.5 Sol-Gel Technologies Ltd
  13.5.1 Sol-Gel Technologies Ltd Company Information
  13.5.2 Sol-Gel Technologies Ltd Retinoic Acid Receptor Beta Product Offered
  13.5.3 Sol-Gel Technologies Ltd Retinoic Acid Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Sol-Gel Technologies Ltd Main Business Overview
  13.5.5 Sol-Gel Technologies Ltd Latest Developments
13.6 Valeant Pharmaceuticals International Inc
  13.6.1 Valeant Pharmaceuticals International Inc Company Information
  13.6.2 Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Beta Product Offered
  13.6.3 Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Valeant Pharmaceuticals International Inc Main Business Overview
  13.6.5 Valeant Pharmaceuticals International Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Retinoic Acid Receptor Beta Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Retinoic Acid Receptor Beta Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Alitretinoin
Table 4. Major Players of SBD-073
Table 5. Major Players of Tamibarotene
Table 6. Major Players of Tazarotene
Table 7. Major Players of Others
Table 8. Global Retinoic Acid Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Retinoic Acid Receptor Beta Sales Market Share by Type (2017-2022)
Table 10. Global Retinoic Acid Receptor Beta Revenue by Type (2017-2022) & ($ million)
Table 11. Global Retinoic Acid Receptor Beta Revenue Market Share by Type (2017-2022)
Table 12. Global Retinoic Acid Receptor Beta Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Retinoic Acid Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Retinoic Acid Receptor Beta Sales Market Share by Application (2017-2022)
Table 15. Global Retinoic Acid Receptor Beta Revenue by Application (2017-2022)
Table 16. Global Retinoic Acid Receptor Beta Revenue Market Share by Application (2017-2022)
Table 17. Global Retinoic Acid Receptor Beta Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Retinoic Acid Receptor Beta Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Retinoic Acid Receptor Beta Sales Market Share by Company (2020-2022)
Table 20. Global Retinoic Acid Receptor Beta Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Retinoic Acid Receptor Beta Revenue Market Share by Company (2020-2022)
Table 22. Global Retinoic Acid Receptor Beta Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Retinoic Acid Receptor Beta Producing Area Distribution and Sales Area
Table 24. Players Retinoic Acid Receptor Beta Products Offered
Table 25. Retinoic Acid Receptor Beta Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Retinoic Acid Receptor Beta Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Retinoic Acid Receptor Beta Sales Market Share Geographic Region (2017-2022)
Table 30. Global Retinoic Acid Receptor Beta Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Retinoic Acid Receptor Beta Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Retinoic Acid Receptor Beta Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Retinoic Acid Receptor Beta Sales Market Share by Country/Region (2017-2022)
Table 34. Global Retinoic Acid Receptor Beta Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Retinoic Acid Receptor Beta Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Retinoic Acid Receptor Beta Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Retinoic Acid Receptor Beta Sales Market Share by Country (2017-2022)
Table 38. Americas Retinoic Acid Receptor Beta Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Retinoic Acid Receptor Beta Revenue Market Share by Country (2017-2022)
Table 40. Americas Retinoic Acid Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Retinoic Acid Receptor Beta Sales Market Share by Type (2017-2022)
Table 42. Americas Retinoic Acid Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Retinoic Acid Receptor Beta Sales Market Share by Application (2017-2022)
Table 44. APAC Retinoic Acid Receptor Beta Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Retinoic Acid Receptor Beta Sales Market Share by Region (2017-2022)
Table 46. APAC Retinoic Acid Receptor Beta Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Retinoic Acid Receptor Beta Revenue Market Share by Region (2017-2022)
Table 48. APAC Retinoic Acid Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Retinoic Acid Receptor Beta Sales Market Share by Type (2017-2022)
Table 50. APAC Retinoic Acid Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Retinoic Acid Receptor Beta Sales Market Share by Application (2017-2022)
Table 52. Europe Retinoic Acid Receptor Beta Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Retinoic Acid Receptor Beta Sales Market Share by Country (2017-2022)
Table 54. Europe Retinoic Acid Receptor Beta Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Retinoic Acid Receptor Beta Revenue Market Share by Country (2017-2022)
Table 56. Europe Retinoic Acid Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Retinoic Acid Receptor Beta Sales Market Share by Type (2017-2022)
Table 58. Europe Retinoic Acid Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Retinoic Acid Receptor Beta Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Retinoic Acid Receptor Beta Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Retinoic Acid Receptor Beta Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Retinoic Acid Receptor Beta Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Retinoic Acid Receptor Beta Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Retinoic Acid Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Retinoic Acid Receptor Beta Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Retinoic Acid Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Retinoic Acid Receptor Beta Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Retinoic Acid Receptor Beta
Table 69. Key Market Challenges & Risks of Retinoic Acid Receptor Beta
Table 70. Key Industry Trends of Retinoic Acid Receptor Beta
Table 71. Retinoic Acid Receptor Beta Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Retinoic Acid Receptor Beta Distributors List
Table 74. Retinoic Acid Receptor Beta Customer List
Table 75. Global Retinoic Acid Receptor Beta Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Retinoic Acid Receptor Beta Sales Market Forecast by Region
Table 77. Global Retinoic Acid Receptor Beta Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Retinoic Acid Receptor Beta Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Retinoic Acid Receptor Beta Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Retinoic Acid Receptor Beta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Retinoic Acid Receptor Beta Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Retinoic Acid Receptor Beta Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Retinoic Acid Receptor Beta Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Retinoic Acid Receptor Beta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Retinoic Acid Receptor Beta Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Retinoic Acid Receptor Beta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Retinoic Acid Receptor Beta Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Retinoic Acid Receptor Beta Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Retinoic Acid Receptor Beta Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Retinoic Acid Receptor Beta Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Retinoic Acid Receptor Beta Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Retinoic Acid Receptor Beta Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Retinoic Acid Receptor Beta Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Retinoic Acid Receptor Beta Revenue Market Share Forecast by Application (2023-2028)
Table 95. 3SBio Inc Basic Information, Retinoic Acid Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 96. 3SBio Inc Retinoic Acid Receptor Beta Product Offered
Table 97. 3SBio Inc Retinoic Acid Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. 3SBio Inc Main Business
Table 99. 3SBio Inc Latest Developments
Table 100. Lee's Pharmaceutical Holdings Ltd Basic Information, Retinoic Acid Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 101. Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Beta Product Offered
Table 102. Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Lee's Pharmaceutical Holdings Ltd Main Business
Table 104. Lee's Pharmaceutical Holdings Ltd Latest Developments
Table 105. Phosphagenics Ltd Basic Information, Retinoic Acid Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 106. Phosphagenics Ltd Retinoic Acid Receptor Beta Product Offered
Table 107. Phosphagenics Ltd Retinoic Acid Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Phosphagenics Ltd Main Business
Table 109. Phosphagenics Ltd Latest Developments
Table 110. Promius Pharma LLC Basic Information, Retinoic Acid Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 111. Promius Pharma LLC Retinoic Acid Receptor Beta Product Offered
Table 112. Promius Pharma LLC Retinoic Acid Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Promius Pharma LLC Main Business
Table 114. Promius Pharma LLC Latest Developments
Table 115. Sol-Gel Technologies Ltd Basic Information, Retinoic Acid Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 116. Sol-Gel Technologies Ltd Retinoic Acid Receptor Beta Product Offered
Table 117. Sol-Gel Technologies Ltd Retinoic Acid Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Sol-Gel Technologies Ltd Main Business
Table 119. Sol-Gel Technologies Ltd Latest Developments
Table 120. Valeant Pharmaceuticals International Inc Basic Information, Retinoic Acid Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 121. Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Beta Product Offered
Table 122. Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Valeant Pharmaceuticals International Inc Main Business
Table 124. Valeant Pharmaceuticals International Inc Latest Developments

LIST OF FIGURES

Figure 1. Picture of Retinoic Acid Receptor Beta
Figure 2. Retinoic Acid Receptor Beta Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Retinoic Acid Receptor Beta Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Retinoic Acid Receptor Beta Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Retinoic Acid Receptor Beta Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Alitretinoin
Figure 10. Product Picture of SBD-073
Figure 11. Product Picture of Tamibarotene
Figure 12. Product Picture of Tazarotene
Figure 13. Product Picture of Others
Figure 14. Global Retinoic Acid Receptor Beta Sales Market Share by Type in 2021
Figure 15. Global Retinoic Acid Receptor Beta Revenue Market Share by Type (2017-2022)
Figure 16. Retinoic Acid Receptor Beta Consumed in Metabolic Disorders
Figure 17. Global Retinoic Acid Receptor Beta Market: Metabolic Disorders (2017-2022) & (K Pcs)
Figure 18. Retinoic Acid Receptor Beta Consumed in Hemotological Disorders
Figure 19. Global Retinoic Acid Receptor Beta Market: Hemotological Disorders (2017-2022) & (K Pcs)
Figure 20. Retinoic Acid Receptor Beta Consumed in Oncology
Figure 21. Global Retinoic Acid Receptor Beta Market: Oncology (2017-2022) & (K Pcs)
Figure 22. Retinoic Acid Receptor Beta Consumed in Others
Figure 23. Global Retinoic Acid Receptor Beta Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Retinoic Acid Receptor Beta Sales Market Share by Application (2017-2022)
Figure 25. Global Retinoic Acid Receptor Beta Revenue Market Share by Application in 2021
Figure 26. Retinoic Acid Receptor Beta Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Retinoic Acid Receptor Beta Revenue Market Share by Company in 2021
Figure 28. Global Retinoic Acid Receptor Beta Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Retinoic Acid Receptor Beta Revenue Market Share by Geographic Region in 2021
Figure 30. Global Retinoic Acid Receptor Beta Sales Market Share by Region (2017-2022)
Figure 31. Global Retinoic Acid Receptor Beta Revenue Market Share by Country/Region in 2021
Figure 32. Americas Retinoic Acid Receptor Beta Sales 2017-2022 (K Pcs)
Figure 33. Americas Retinoic Acid Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 34. APAC Retinoic Acid Receptor Beta Sales 2017-2022 (K Pcs)
Figure 35. APAC Retinoic Acid Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 36. Europe Retinoic Acid Receptor Beta Sales 2017-2022 (K Pcs)
Figure 37. Europe Retinoic Acid Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Retinoic Acid Receptor Beta Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Retinoic Acid Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 40. Americas Retinoic Acid Receptor Beta Sales Market Share by Country in 2021
Figure 41. Americas Retinoic Acid Receptor Beta Revenue Market Share by Country in 2021
Figure 42. United States Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Retinoic Acid Receptor Beta Sales Market Share by Region in 2021
Figure 47. APAC Retinoic Acid Receptor Beta Revenue Market Share by Regions in 2021
Figure 48. China Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Retinoic Acid Receptor Beta Sales Market Share by Country in 2021
Figure 55. Europe Retinoic Acid Receptor Beta Revenue Market Share by Country in 2021
Figure 56. Germany Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Retinoic Acid Receptor Beta Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Retinoic Acid Receptor Beta Revenue Market Share by Country in 2021
Figure 63. Egypt Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Retinoic Acid Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Retinoic Acid Receptor Beta in 2021
Figure 69. Manufacturing Process Analysis of Retinoic Acid Receptor Beta
Figure 70. Industry Chain Structure of Retinoic Acid Receptor Beta
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


More Publications